Drug-resistant tuberculosis transmission and resistance amplification within families

Emerging Infectious Diseases

Volumn 18, Issue 8, 2012, Pages 1342-1345

  Seddon, James A ^a,b   Warren, Rob M ^b   Enarson, Donald A ^c   Beyers, Nulda ^b   Simon Schaaf, H ^b,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLARITHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LINEZOLID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TERIZIDONE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; DEATH; DISEASE RESISTANCE; DNA FINGERPRINTING; DNA SEQUENCE; DRUG MEGADOSE; DRUG RESISTANT TUBERCULOSIS; FAMILY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FAMILY; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84864445023     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1808.111650     Document Type: Article

References (10)

1. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2008;12:99-104.
2. Schaaf HS, Marais BJ, Hesseling AC, Brittle W, Donald PR. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa-an upward trend. Am J Public Health. 2009;99:1486-90. http://dx.doi.org/10.2105/AJPH.2008.143271
3. Driver CR, Cordova IM, Munsiff SS. Targeting tuberculosis testing: the yield of source case investigations for young children with reactive tuberculin skin tests. Public Health Rep. 2002;117:366-72.
4. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907-14.
5. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
6. Streicher EM, Victor TC, van der Spuy G, Sola C, Rastogi N, van Helden PD, et al. Spoligotype signatures in the Mycobacterium tuberculosis complex. J Clin Microbiol. 2007;45:237-40. http://dx.doi.org/10.1128/JCM.01429-06
7. Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006;8:97-111.
8. Streicher EM, Muller B, Chihota V, Mlambo C, Tait M, Pillay M, et al. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect Genet Evol. 2012;12:686-94. http://dx.doi.org/10.1016/j.meegid.2011.07.019
9. Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Eur J Clin Microbiol Infect Dis. 2000;19:132-6. http://dx.doi.org/10.1007/s100960050445
10. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Policy statement. 2011 [cited 2012 Jun 11]. http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf